NO981356L - Tiofenpyrimidiner - Google Patents

Tiofenpyrimidiner

Info

Publication number
NO981356L
NO981356L NO981356A NO981356A NO981356L NO 981356 L NO981356 L NO 981356L NO 981356 A NO981356 A NO 981356A NO 981356 A NO981356 A NO 981356A NO 981356 L NO981356 L NO 981356L
Authority
NO
Norway
Prior art keywords
tiofenpyrimidiner
Prior art date
Application number
NO981356A
Other languages
English (en)
Norwegian (no)
Other versions
NO981356D0 (no
Inventor
Chen Chen
James R Mccarthy
Thomas R Webb
Terence J Moran
Original Assignee
Janssen Pharmaceutica Nv
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv, Neurocrine Biosciences Inc filed Critical Janssen Pharmaceutica Nv
Publication of NO981356D0 publication Critical patent/NO981356D0/no
Publication of NO981356L publication Critical patent/NO981356L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO981356A 1996-02-07 1998-03-25 Tiofenpyrimidiner NO981356L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1127496P 1996-02-07 1996-02-07
US2768996P 1996-10-08 1996-10-08
PCT/EP1997/000457 WO1997029110A1 (en) 1996-02-07 1997-01-30 Thiophenopyrimidines

Publications (2)

Publication Number Publication Date
NO981356D0 NO981356D0 (no) 1998-03-25
NO981356L true NO981356L (no) 1998-07-09

Family

ID=26682201

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981356A NO981356L (no) 1996-02-07 1998-03-25 Tiofenpyrimidiner

Country Status (17)

Country Link
US (2) US6255310B1 (id)
EP (1) EP0882051B1 (id)
JP (1) JP2000504678A (id)
KR (1) KR19990067390A (id)
AR (1) AR005731A1 (id)
AT (1) ATE208395T1 (id)
CA (1) CA2233307A1 (id)
DE (1) DE69708059T2 (id)
DK (1) DK0882051T3 (id)
ES (1) ES2167710T3 (id)
ID (1) ID15904A (id)
MY (1) MY119118A (id)
NO (1) NO981356L (id)
NZ (1) NZ330118A (id)
PT (1) PT882051E (id)
TW (1) TW448178B (id)
WO (1) WO1997029110A1 (id)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
CA2309690A1 (en) 1997-11-11 1999-05-20 Pfizer Products Inc. Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
DE19837387A1 (de) * 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
IL148903A0 (en) 1999-09-30 2002-09-12 Neurogen Corp Certain alkylene diamine-substituted heterocycles
CO5271670A1 (es) * 1999-10-29 2003-04-30 Pfizer Prod Inc Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
TWI271406B (en) 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
JP2003535867A (ja) 2000-06-06 2003-12-02 ファイザー プロダクツ インコーポレイテッド 抗癌剤として有用なチオフェン誘導体
US6503914B1 (en) * 2000-10-23 2003-01-07 Board Of Regents, The University Of Texas System Thienopyrimidine-based inhibitors of the Src family
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
WO2002088121A1 (en) 2001-04-27 2002-11-07 Eisai Co., Ltd. Pyrazolo[1,5-a]pyridines and medicines containing the same
US7285557B2 (en) * 2001-10-15 2007-10-23 Smithkline Beecham P.L.C. Pyrimidinones as melanin concentrating hormone receptor 1
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
US20100189797A1 (en) 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
US7671047B2 (en) * 2002-06-19 2010-03-02 Sanofi-Aventis Deutschland Gmbh Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
SI1555265T1 (sl) 2002-10-22 2009-06-30 Eisai R&D Man Co Ltd 7-fenil pirazolopiridinske spojine
US7176216B2 (en) 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
US20050001673A1 (en) * 2002-10-29 2005-01-06 Zvi Regev Direct digital frequency modulation / phase modulation decoder
US20060071832A1 (en) * 2002-10-29 2006-04-06 Zvi Regev Instantaneous phase digitizer
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
RU2006128580A (ru) 2004-01-06 2008-02-20 Тайсо Фармасьютикал Ко., Лтд. (Jp) Производные тиенопиримидина и тиенопиридина, замещенные циклической аминогруппой
EP1706410A2 (en) 2004-01-06 2006-10-04 Taisho Pharmaceutical Co., Ltd Pyrrolopyrimidine and pyrrolotriazine derivatives as crf receptor antagonists
AU2005227322A1 (en) 2004-03-23 2005-10-06 Biogen Idec Ma Inc. Receptor coupling agents and therapeutic uses thereof
NZ551782A (en) 2004-06-03 2010-03-26 Athlomics Pty Ltd Agents and methods for diagnosing stress
JP2007161585A (ja) 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
JP5089395B2 (ja) 2004-10-29 2012-12-05 バイオクライスト ファーマシューティカルズ， インコーポレイテッド 治療用フロピリミジンおよびチエノピリミジン
EP1863500A2 (en) 2005-03-29 2007-12-12 Biocryst Pharmaceuticals, Inc. Hepatitis c therapies
WO2008082839A2 (en) * 2006-12-29 2008-07-10 Abbott Laboratories Pim kinase inhibitors as cancer chemotherapeutics
RS52561B (sr) 2008-04-15 2013-04-30 Eisai R&D Management Co., Ltd. Jedinjenje 3-fenilpirazolo[5,1-b]tiazol
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
WO2017047090A1 (ja) 2015-09-18 2017-03-23 日本電気株式会社 指紋撮像システム、指紋撮像装置、画像処理装置、指紋撮像方法、及び記録媒体
JP7114076B2 (ja) 2015-12-22 2022-08-08 シャイ・セラピューティクス・エルエルシー がん及び炎症性疾患の処置のための化合物
JP7514005B2 (ja) 2017-06-21 2024-07-10 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのｒａｓスーパーファミリーと相互作用する化合物
JP7407461B2 (ja) 2018-12-19 2024-01-04 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
CN110590807B (zh) * 2019-10-09 2022-01-07 陕西理工大学 一种噻吩并[3,2-d]嘧啶类衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2121950A1 (en) 1971-05-04 1972-11-23 Dr. Karl Thomae Gmbh, 7950 Biberach Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
DE3277623D1 (en) * 1981-07-31 1987-12-17 Sloan Kettering Inst Cancer Anti-leukemic beta-glycosyl c-nucleosides
US5063245A (en) * 1990-03-28 1991-11-05 Nova Pharmaceutical Corporation Corticotropin-releasing factor antagonism compounds
BR9101256A (pt) * 1990-03-30 1991-11-05 Dowelanco Composto,composicao fungicida,processo fungicida,composicao inseticida ou acaricida e processo inseticida ou acaricida
ATE177101T1 (de) * 1992-12-17 1999-03-15 Pfizer Pyrrolopyrimidine als crf antagonisten
TW370529B (en) * 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists
US6020492A (en) 1995-05-12 2000-02-01 Neurogen Corporation Deazapurine derivatives; a new class of CRF1 specific ligands

Also Published As

Publication number Publication date
DK0882051T3 (da) 2002-02-25
MY119118A (en) 2005-03-31
WO1997029110A1 (en) 1997-08-14
PT882051E (pt) 2002-04-29
AR005731A1 (es) 1999-07-14
ATE208395T1 (de) 2001-11-15
NZ330118A (en) 2000-03-27
CA2233307A1 (en) 1997-08-14
ID15904A (id) 1997-08-14
US6255310B1 (en) 2001-07-03
US6469166B2 (en) 2002-10-22
US20020052362A1 (en) 2002-05-02
EP0882051B1 (en) 2001-11-07
TW448178B (en) 2001-08-01
EP0882051A1 (en) 1998-12-09
AU1720997A (en) 1997-08-28
NO981356D0 (no) 1998-03-25
DE69708059D1 (en) 2001-12-13
DE69708059T2 (de) 2002-07-18
KR19990067390A (ko) 1999-08-16
AU725674B2 (en) 2000-10-19
JP2000504678A (ja) 2000-04-18
ES2167710T3 (es) 2002-05-16

Similar Documents

Publication Publication Date Title
DE69714798D1 (de) Blutentnahmröhrchen
DE69736584D1 (de) Benutzereingabeabtastvorrichtung
NO984120D0 (no) Triarylforbindelser
DE69734622D1 (de) Leitstrahlrichtungseinstellvorrichtung
ATE208395T1 (de) Thiophenopyrimidine
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
DE69631845D1 (de) Musterextrahierungsgerät
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
FI961556A0 (fi) Luftavskiljare
DE69618202D1 (de) Haarklip
FI961889A0 (fi) Axialkolvmaskin
ATE267568T1 (de) Epithese
FI2888U1 (fi) Paalileikkuri
BR9603698A (pt) Hidro-escova dorso-lombar
BR9601152A (pt) Drenovaporvia
NO964880L (no) Betongsöylefundament
FI960814A0 (fi) Piskstaellning
FI960763A0 (fi) Vattenkraftverk
NO985390L (no) Plogskjµr
BR7602320U (pt) Supedânea
BR9603976A (pt) Stop-entope
FI964750A0 (fi) Vaetskefoerpackningsarrangemang
BR7603380U (pt) Abratporta
BR9603975A (pt) Fix-catch

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application